Top performing · Industry · ranked by 1-year total return

Top-performing Biotechnology ETFs

There are 18 US-listed biotechnology ETFs, with $24.73B in combined net assets.

Over the year to Nov 6, 2026, the best performer among funds with at least $25 million in assets was BBC (+45.6%); the median fund returned +36.5%.

Expense ratios run from 0.19% to 1.07% a year (median 0.54%).

The 10 top performers

Top-performing Biotechnology ETFs
# Fund 30 daysNet assetsCostYield1 moYTD1 yr3 yr5 yr
1 BBC Virtus LifeSci Biotech Clinical Trials ETF $46.4M0.65%1.53%-0.5%+11.6%+45.6%+33.1%-1.4%
2 LFSC F/M Emerald Life Sciences Innovation ETF $126.3M0.54%—+6.6%+22.6%+43.4%——
3 BBH VanEck Biotech ETF $395.6M0.35%0.38%+7.3%+33.9%+40.2%+19.2%+6.3%
4 XBI SPDR S&P Biotech ETF $10.73B0.35%0.36%+0.9%+25.0%+39.9%+29.9%+3.1%
5 BBP Virtus LifeSci Biotech Products ETF $98.5M0.34%0%+1.3%+28.0%+37.9%+28.0%+14.4%
6 IBBQ Invesco Nasdaq Biotechnology ETF $96.4M0.19%1.09%+5.7%+27.3%+36.7%+24.2%—
7 FBT First Trust NYSE Arca Biotechnology Index Fund $2.81B0.55%0%+0.5%+28.9%+36.5%+24.3%+10.6%
8 CANC Tema Oncology ETF $176.1M0.75%0.05%+3.4%+20.5%+35.3%+23.5%—
9 IBB iShares Biotechnology ETF $9.09B0.44%0.15%+5.2%+26.7%+35.1%+21.7%+6.6%
10 PBE Invesco Biotechnology & Genome ETF $281.9M0.59%1.34%+4.6%+21.9%+31.8%+22.1%+6.4%

Funds with less than $25 million in net assets and the 4 leveraged or inverse funds are left out of the ranking. Returns are total returns with distributions reinvested (3 and 5 years annualized), as of Nov 6, 2026.

How the top 5 compare

    Growth of each fund’s value from the start of the range, distributions reinvested. The dashed gray line is the S&P 500 (SPY).

    All 18 Biotechnology ETFs

    Largest first. Click a heading to sort.

    All Biotechnology ETFs
    Fund IssuerNet assetsCostYieldYTD1 yr5 yr
    XBI SPDR S&P Biotech ETF SPDR (State Street)$10.73B0.35%0.36%+25.0%+39.9%+3.1%
    IBB iShares Biotechnology ETF iShares$9.09B0.44%0.15%+26.7%+35.1%+6.6%
    FBT First Trust NYSE Arca Biotechnology Index Fund First Trust$2.81B0.55%0%+28.9%+36.5%+10.6%
    LABU Direxion Daily S&P Biotech Bull 3x Shares Leveraged Direxion$494.4M0.96%0.41%+40.4%+89.3%-28.5%
    BBH VanEck Biotech ETF VanEck$395.6M0.35%0.38%+33.9%+40.2%+6.3%
    PBE Invesco Biotechnology & Genome ETF Invesco$281.9M0.59%1.34%+21.9%+31.8%+6.4%
    CANC Tema Oncology ETF Tema Global Ltd.$176.1M0.75%0.05%+20.5%+35.3%—
    SBIO ALPS Medical Breakthroughs ETF ALPS$161.8M0.5%0%+8.9%+26.0%+3.6%
    LFSC F/M Emerald Life Sciences Innovation ETF 1251 Capital Group Inc.$126.3M0.54%—+22.6%+43.4%—
    BIB ProShares Ultra Nasdaq Biotechnology Leveraged ProShares$101.4M0.95%0.19%+47.7%+68.0%+6.1%
    BBP Virtus LifeSci Biotech Products ETF Virtus Investment Partners$98.5M0.34%0%+28.0%+37.9%+14.4%
    IBBQ Invesco Nasdaq Biotechnology ETF Invesco$96.4M0.19%1.09%+27.3%+36.7%—
    LABD Direxion Daily S&P Biotech Bear 3x Shares Inverse Direxion$54.2M1.07%6.49%-64.8%-75.6%-46.9%
    FMED Fidelity Disruptive Medicine ETF Fidelity$51.5M0.5%0%+17.0%+21.9%—
    BBC Virtus LifeSci Biotech Clinical Trials ETF Virtus Investment Partners$46.4M0.65%1.53%+11.6%+45.6%-1.4%
    CNCR Range Cancer Therapeutics ETF Exchange Traded Concepts$8.9M0.79%0%0.0%0.0%-20.0%
    WDNA WisdomTree BioRevolution Fund WisdomTree$2.7M0.45%3.33%+36.8%+49.4%-1.1%
    BIS ProShares UltraShort Nasdaq Biotechnology Inverse ProShares$1.9M0.95%4.26%-42.9%-50.6%-21.2%